tip

tip

TIP A COLLEAGUE

Key Publications

Onset of action in depression

Using meta-regression in performing indirect comparisons: comparing escitalopram with venlafaxine XR

Eckert L. et al. Curr Med Res Opin 2006; 22(11):2313-2321

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

Lepola UM. et al. Int Clin Psychopharmacol 2003; 18:211-217

Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder

Lepola UM. et al. Int Clin Psychopharmacol 2004; 19(3):149-55

Efficacy of escitalopram in patients with severe depression: a pooled analysis

Llorca PM. et al. Int J Clin Pract 2005; 59(3):268-75

Escitalopram versus venlafaxine XR in the treatment of depression

Montgomery SA. et al. Int Clin Psychopharmacol 2006; 21:297-309

Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model

Montgomery SA. et al. Pharmacol Toxicol 2001; 88:282-286

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

Montgomery SA. et al. Neuropsychobiology 2004; 50(1):57-64

Escitalopram and suicidality in adult depression and anxiety

Pedersen AG. et al. Int Clin Psychopharmacol 2005; 20:139-143

The onset of effect for escitalopram and its relevance for the clinical management of depression

Wade A. et al. Curr Med Res Opin 2006; 22(11):2101-2110

Published: 22/05/2006 Last updated: 09/11/2010

www.irecover.com www.mypdinfo.com www.ebixa.com www.azilect.eu Disclaimer

H. Lundbeck A/S - Ottiliavej 9 - DK-2500 Copenhagen Valby - Phone +45 3630 1311 - Contact us